Elise A. Chong
- Oncology top 1%
- CAR-T cell therapy research 62
- Viral-associated cancers and disorders 10
- Cancer Immunotherapy and Biomarkers 8
-
- Lymphoma Diagnosis and Treatment 61
- Immunology top 5%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 24
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 24
-
- CNS Lymphoma Diagnosis and Treatment 11
-
- Multiple Myeloma Research and Treatments 10
-
- Cutaneous lymphoproliferative disorders research 10
- Co-authors
- Stephen J. SchusterSunita D. NastaJakub SvobodaDaniel J. LandsburgAnthony R. MatoSimon F. LaceyCarl H. JuneDavid L. Porter
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (13 papers)Blood (46 papers)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Elise A. Chong
103 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 2.1k
- Pathology and Forensic Medicine 711
- Immunology 638
- Genetics 285
- Genetics 472
Countries citing papers authored by Elise A. Chong
This map shows the geographic impact of Elise A. Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elise A. Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elise A. Chong more than expected).
Fields of papers citing papers by Elise A. Chong
This network shows the impact of papers produced by Elise A. Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elise A. Chong. The network helps show where Elise A. Chong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elise A. Chong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 11 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 4 | |
| 13 | 2021 | 7 | |
| 14 | 2018 | 3 | |
| 15 | 2017 | 17 | |
| 16 | Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomasbreakdown → | 2017 | 1266 |
| 17 | 2015 | 46 | |
| 18 | 2015 | 113 | |
| 19 | 2007 | 12 | |
| 20 | 2007 | 13 |
About Elise A. Chong
Elise A. Chong is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 110 papers that have together received 2.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (62 papers), Lymphoma Diagnosis and Treatment (61 papers), Chronic Lymphocytic Leukemia Research (24 papers), CNS Lymphoma Diagnosis and Treatment (11 papers), Multiple Myeloma Research and Treatments (10 papers), Cutaneous lymphoproliferative disorders research (10 papers), Viral-associated cancers and disorders (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Oncology (2.1k citations), Pathology and Forensic Medicine (711 citations) and Immunology (638 citations). Elise A. Chong has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Stephen J. Schuster, Sunita D. Nasta, Jakub Svoboda, Daniel J. Landsburg, Anthony R. Mato, Simon F. Lacey, Carl H. June, David L. Porter, Bruce L. Levine and J. Joseph Melenhorst. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.